{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:53:30Z","timestamp":1791359610127,"version":"4.3.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s11060-026-05759-1","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T03:12:31Z","timestamp":1787627551000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical, radiographic, and neuropathologic characterization of peripherally hyperenhancing brain metastases: a novel radiographic entity"],"prefix":"10.1007","volume":"179","author":[{"given":"Ryan M.","family":"Shute","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rifaquat","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyam","family":"Tanguturi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Catalano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daphne A.","family":"Haas-Kogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick Y.","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Meredith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenya Linda","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Verry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey P.","family":"Guenette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nayan","family":"Lamba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayal A.","family":"Aizer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,25]]},"reference":[{"key":"5759_CR1","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1093\/neuonc\/noac118","volume":"24","author":"AA Aizer","year":"2022","unstructured":"Aizer AA, Lamba N, Ahluwalia MS, Aldape K, Boire A, Brastianos PK, Brown PD, Camidge DR, Chiang VL, Davies MA, Hu LS, Huang RY, Kaufmann T, Kumthekar P, Lam K, Lee EQ, Lin NU, Mehta M, Parsons M, Reardon DA, Sheehan J, Soffietti R, Tawbi H, Weller M, Wen PY (2022) Brain metastases: A Society for Neuro-Oncology (SNO) consensus review on current management and future directions. Neuro Oncol 24:1613\u20131646. https:\/\/doi.org\/10.1093\/neuonc\/noac118","journal-title":"Neuro Oncol"},{"key":"5759_CR2","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1200\/JCO.2006.09.9861","volume":"25","author":"LL Muldoon","year":"2007","unstructured":"Muldoon LL, Soussain C, Jahnke K, Johanson C, Siegal T, Smith QR, Hall WA, Hynynen K, Senter PD, Peereboom DM, Neuwelt EA (2007) Chemotherapy delivery issues in central nervous system malignancy: a reality check. J Clin Oncol 25:2295\u20132305. https:\/\/doi.org\/10.1200\/JCO.2006.09.9861","journal-title":"J Clin Oncol"},{"key":"5759_CR3","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1093\/neuonc\/noab101","volume":"23","author":"N Lamba","year":"2021","unstructured":"Lamba N, Wen PY, Aizer AA (2021) Epidemiology of brain metastases and leptomeningeal disease. Neuro Oncol 23:1447\u20131456. https:\/\/doi.org\/10.1093\/neuonc\/noab101","journal-title":"Neuro Oncol"},{"key":"5759_CR4","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/S1470-2045(09)70263-3","volume":"10","author":"EL Chang","year":"2009","unstructured":"Chang EL, Wefel JS, Hess KR, Allen PK, Lang FF, Kornguth DG, Arbuckle RB, Swint JM, Shiu AS, Maor MH, Meyers CA (2009) Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol 10:1037\u20131044 09)70263-3 S1470-2045(09)70263-3 [pii]","journal-title":"Lancet Oncol"},{"key":"5759_CR5","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1200\/JCO.2010.30.1655","volume":"29","author":"M Kocher","year":"2011","unstructured":"Kocher M, Soffietti R, Abacioglu U, Villa S, Fauchon F, Baumert BG, Fariselli L, Tzuk-Shina T, Kortmann RD, Carrie C, Ben Hassel M, Kouri M, Valeinis E, van den Berge D, Collette S, Collette L, Mueller RP (2011) Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952\u201326001 study. J Clin Oncol 29:134\u2013141. https:\/\/doi.org\/10.1200\/JCO.2010.30.1655JCO.2010.30.1655 [pii]","journal-title":"J Clin Oncol"},{"key":"5759_CR6","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1001\/jama.2016.9839","volume":"316","author":"PD Brown","year":"2016","unstructured":"Brown PD, Jaeckle K, Ballman KV, Farace E, Cerhan JH, Anderson SK, Carrero XW, Barker FG 2nd, Deming R, Burri SH, Menard C, Chung C, Stieber VW, Pollock BE, Galanis E, Buckner JC, Asher AL (2016) Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases: A Randomized Clinical Trial. JAMA 316:401\u2013409. https:\/\/doi.org\/10.1001\/jama.2016.9839","journal-title":"JAMA"},{"key":"5759_CR7","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/S1470-2045(17)30441-2","volume":"18","author":"PD Brown","year":"2017","unstructured":"Brown PD, Ballman KV, Cerhan JH, Anderson SK, Carrero XW, Whitton AC, Greenspoon J, Parney IF, Laack NNI, Ashman JB, Bahary JP, Hadjipanayis CG, Urbanic JJ, Barker FG 2nd, Farace E, Khuntia D, Giannini C, Buckner JC, Galanis E, Roberge D (2017) Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C\/CEC.3): a multicentre, randomised, controlled, phase 3 trial. Lancet Oncol 18:1049\u20131060. https:\/\/doi.org\/10.1016\/S1470-2045(17)30441-2","journal-title":"Lancet Oncol"},{"key":"5759_CR8","doi-asserted-by":"publisher","first-page":"2986","DOI":"10.1200\/JCO-25-00056","volume":"43","author":"AA Aizer","year":"2025","unstructured":"Aizer AA, Tanguturi SK, Shi DD, Catalano PJ, Shin KY, Ricca I, Johnson M, Benham G, Kozono DE, Mak RH, Hertan L, Chipidza F, Krishnan M, Pashtan I, Peng L, Qian JM, Shiloh RY, Cagney DN, Sands J, Brown PD, Wen PY, Haas-Kogan DA, Rahman R (2025) Stereotactic Radiosurgery in Patients With Small Cell Lung Cancer and 1\u201310 Brain Metastases: A Multi-Institutional, Phase II, Prospective Clinical Trial. J Clin Oncol 43:2986\u20132997. https:\/\/doi.org\/10.1200\/JCO-25-00056","journal-title":"J Clin Oncol"},{"key":"5759_CR9","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2026.0076","author":"AA Aizer","year":"2026","unstructured":"Aizer AA, Shin KY, Catalano PJ, Ricca I, Johnson M, Benham G, Roper K, Spicer B, Mann E, Nosker J, Parsons MW, Mendu ML, Hepel J, Chipidza F, Krishnan M, Shi DD, Lamba N, Pashtan I, Peng L, Alexander B, Brown PD, Wen PY, Haas-Kogan DA, Rahman R, Tanguturi S (2026) Treatment for Brain Metastases With Stereotactic Radiation vs Hippocampal-Avoidance Whole Brain Radiation: A Randomized Clinical Trial. JAMA. https:\/\/doi.org\/10.1001\/jama.2026.0076","journal-title":"JAMA"},{"key":"5759_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-025-05023-y","author":"NS Rashid","year":"2025","unstructured":"Rashid NS, Lamba N, Catalano PJ, Elhalawani H, Tanguturi SK, Rahman R, Haas-Kogan DA, Wen PY, Aizer AA (2025) Impact of brain metastasis size at the time of radiotherapy on local control and radiation necrosis. J Neurooncol. https:\/\/doi.org\/10.1007\/s11060-025-05023-y","journal-title":"J Neurooncol"},{"key":"5759_CR11","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1056\/NEJM199002223220802","volume":"322","author":"RA Patchell","year":"1990","unstructured":"Patchell RA, Tibbs PA, Walsh JW, Dempsey RJ, Maruyama Y, Kryscio RJ, Markesbery WR, Macdonald JS, Young B (1990) A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 322:494\u2013500. https:\/\/doi.org\/10.1056\/NEJM199002223220802","journal-title":"N Engl J Med"},{"key":"5759_CR12","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.02314","author":"MA Vogelbaum","year":"2021","unstructured":"Vogelbaum MA, Brown PD, Messersmith H, Brastianos PK, Burri S, Cahill D, Dunn IF, Gaspar LE, Gatson NTN, Gondi V, Jordan JT, Lassman AB, Maues J, Mohile N, Redjal N, Stevens G, Sulman E, van den Bent M, Wallace HJ, Weinberg JS, Zadeh G, Schiff D (2021) Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline. J Clin Oncol: JCO2102314. https:\/\/doi.org\/10.1200\/JCO.21.02314","journal-title":"J Clin Oncol: JCO2102314"},{"key":"5759_CR13","doi-asserted-by":"publisher","first-page":"3728","DOI":"10.1038\/s41467-024-47998-8","volume":"15","author":"CI Ene","year":"2024","unstructured":"Ene CI, Abi Faraj C, Beckham TH, Weinberg JS, Andersen CR, Haider AS, Rao G, Ferguson SD, Alvarez-Brenkenridge CA, Kim BYS, Heimberger AB, McCutcheon IE, Prabhu SS, Wang CM, Ghia AJ, McGovern SL, Chung C, McAleer MF, Tom MC, Perni S, Swanson TA, Yeboa DN, Briere TM, Huse JT, Fuller GN, Lang FF, Li J, Suki D, Sawaya RE (2024) Response of treatment-naive brain metastases to stereotactic radiosurgery. Nat Commun 15:3728. https:\/\/doi.org\/10.1038\/s41467-024-47998-8","journal-title":"Nat Commun"},{"key":"5759_CR14","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.ijrobp.2017.09.047","volume":"100","author":"H Soliman","year":"2018","unstructured":"Soliman H, Ruschin M, Angelov L, Brown PD, Chiang VLS, Kirkpatrick JP, Lo SS, Mahajan A, Oh KS, Sheehan JP, Soltys SG, Sahgal A (2018) Consensus Contouring Guidelines for Postoperative Completely Resected Cavity Stereotactic Radiosurgery for Brain Metastases. Int J Radiat Oncol Biol Phys 100:436\u2013442. https:\/\/doi.org\/10.1016\/j.ijrobp.2017.09.047","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5759_CR15","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.ijrobp.2014.09.004","volume":"91","author":"JP Kirkpatrick","year":"2015","unstructured":"Kirkpatrick JP, Wang Z, Sampson JH, McSherry F, Herndon JE 2nd, Allen KJ, Duffy E, Hoang JK, Chang Z, Yoo DS, Kelsey CR, Yin FF (2015) Defining the optimal planning target volume in image-guided stereotactic radiosurgery of brain metastases: results of a randomized trial. Int J Radiat Oncol Biol Phys 91:100\u2013108. https:\/\/doi.org\/10.1016\/j.ijrobp.2014.09.004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5759_CR16","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.ijrobp.2006.03.050","volume":"66","author":"BG Baumert","year":"2006","unstructured":"Baumert BG, Rutten I, Dehing-Oberije C, Twijnstra A, Dirx MJ, Debougnoux-Huppertz RM, Lambin P, Kubat B (2006) A pathology-based substrate for target definition in radiosurgery of brain metastases. Int J Radiat Oncol Biol Phys 66:187\u2013194. https:\/\/doi.org\/10.1016\/j.ijrobp.2006.03.050","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5759_CR17","doi-asserted-by":"publisher","first-page":"1592543","DOI":"10.3389\/fnhum.2025.1592543","volume":"19","author":"X Mao","year":"2025","unstructured":"Mao X, Li J, Zheng X, Wang Y, Gao J, Fu C, Li X, Liang M, Wang X, Qiu T, Du H, Xue C, Liu Y (2025) New imaging findings of tumor invasion into brain tissue: Peritumoral Hyperintense Enhancement Sign. Front Hum Neurosci 19:1592543. https:\/\/doi.org\/10.3389\/fnhum.2025.1592543","journal-title":"Front Hum Neurosci"},{"key":"5759_CR18","doi-asserted-by":"publisher","first-page":"6078","DOI":"10.1158\/1078-0432.CCR-17-0560","volume":"23","author":"SH Patel","year":"2017","unstructured":"Patel SH, Poisson LM, Brat DJ, Zhou Y, Cooper L, Snuderl M, Thomas C, Franceschi AM, Griffith B, Flanders AE, Golfinos JG, Chi AS, Jain R (2017) T2-FLAIR Mismatch, an Imaging Biomarker for IDH and 1p\/19q Status in Lower-grade Gliomas: A TCGA\/TCIA Project. Clin Cancer Res 23:6078\u20136085. https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-0560","journal-title":"Clin Cancer Res"},{"key":"5759_CR19","doi-asserted-by":"publisher","first-page":"5289","DOI":"10.1007\/s00330-020-07467-4","volume":"31","author":"SI Park","year":"2021","unstructured":"Park SI, Suh CH, Guenette JP, Huang RY, Kim HS (2021) The T2-FLAIR mismatch sign as a predictor of IDH-mutant, 1p\/19q-noncodeleted lower-grade gliomas: a systematic review and diagnostic meta-analysis. Eur Radiol 31:5289\u20135299. https:\/\/doi.org\/10.1007\/s00330-020-07467-4","journal-title":"Eur Radiol"},{"key":"5759_CR20","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1097\/RLI.0000000000000526","volume":"54","author":"LK Young","year":"2019","unstructured":"Young LK, Gandy SJ, Priba L, Matthew SZ, Graeme Houston J (2019) The Impact of Different Magnetic Resonance Imaging Equipment and Scanning Parameters on Signal Intensity Ratio Measurements in Phantoms and Healthy Volunteers: Implications for Interpreting Gadolinium Signal Changes Within the Brain. Invest Radiol 54:169\u2013176. https:\/\/doi.org\/10.1097\/RLI.0000000000000526","journal-title":"Invest Radiol"},{"key":"5759_CR21","doi-asserted-by":"publisher","first-page":"104066","DOI":"10.1016\/j.media.2026.104066","volume":"111","author":"Q Yang","year":"2026","unstructured":"Yang Q, Shomal-Zadeh F, Gholipour A (2026) Harmonization in magnetic resonance imaging: A survey of acquisition, image-level, and feature-level methods. Med Image Anal 111:104066. https:\/\/doi.org\/10.1016\/j.media.2026.104066","journal-title":"Med Image Anal"},{"key":"5759_CR22","doi-asserted-by":"publisher","unstructured":"Kruk L, Mamtimin M, Braun A, Anders HJ, Andrassy J, Gudermann T, Mammadova-Bach E (2023) Inflammatory networks in renal cell carcinoma. Cancers (Basel) 15. https:\/\/doi.org\/10.3390\/cancers15082212","DOI":"10.3390\/cancers15082212"},{"key":"5759_CR23","doi-asserted-by":"publisher","unstructured":"Wilkinson ID, Jellineck DA, Levy D, Giesel FL, Romanowski CA, Miller BA, Griffiths PD (2006) Dexamethasone and enhancing solitary cerebral mass lesions: alterations in perfusion and blood-tumor barrier kinetics shown by magnetic resonance imaging. Neurosurgery 58: 640\u2013646; discussion 640\u2013646 https:\/\/doi.org\/10.1227\/01.NEU.0000204873.68395.A0","DOI":"10.1227\/01.NEU.0000204873.68395.A0"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-026-05759-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-026-05759-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-026-05759-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:34:40Z","timestamp":1791358480000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-026-05759-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["5759"],"URL":"https:\/\/doi.org\/10.1007\/s11060-026-05759-1","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,25]]},"assertion":[{"value":"23 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Dana-Farber\/Harvard Cancer Center Institutional Review Board approved of the study.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dana-Farber\/Harvard Cancer Center Institutional Review Board waived the requirement for informed consent.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Author A.A.A. reports research funding from Varian and NH TheraAguix \/ TherAguix. Author R.R. reports consulting from the National Brain Tumor Society and St. Lucia, as well as honoria from Servier and advisory board fees from Servier and Telix. Author D.A.H-K. reports non-financial support from Artios Pharma and consulting fees from Gerson Lehrman Group and Guidepoint. Author P.Y.W. reports grants or contracts from AstraZeneca, Black Diamond, Bristol Myers Squibb, Chimerix, Erasca, Global Coalition for Adaptive Research, MediciNova, Merck, Nerviano, Novartis, Philogen, Quadriga, Servier, and VBI Vaccines, royalties from UpToDate, honoraria for lectures or educational events from Alexion\/AstraZeneca, Black Diamond, Bristol Myers Squibb, Chimerix\/Jazz, Day One Bio, Fore Biotherapeutics, Genenta, Glaxo Smith Kline, Imvax, Merck, Novartis, Novocure, Nuvation Bio, Rigel, Servier, and Telix, and advisory board participation for Day One Bio and Novocure. Author J.P.G. reports research funding from the National Institute of Biomedical Imaging and Bioengineering. The authors have no further relevant financial or non-financial interests to disclose.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"53"}}